publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
b
r
z
j
n
f
e
c
respiratori
tract
infect
viral
pneumonia
revers
transcriptas
polymeras
chain
reaction
adult
hospit
b
r
c
human
rhinoviru
hrv
emerg
viral
pathogen
aim
character
group
patient
admit
due
infect
agent
gener
hospit
chile
method
case
identifi
rtpcr
year
activ
surveil
patient
admit
sever
respiratori
ill
diagnosi
avail
hospit
thirtytwo
case
identifi
year
old
comorbid
condit
human
rhinovirusrel
admiss
repres
hospit
due
sever
acut
respiratori
infect
among
adult
rank
second
influenza
patient
present
pneumonia
decompens
chronic
lung
condit
heart
failur
influenzalik
ill
admiss
intens
intermedi
care
unit
requir
inhospit
mortal
reach
score
significantli
associ
inhospit
mortal
p
patient
receiv
antibiot
conclus
human
rhinoviru
infect
elderli
patient
comorbid
condit
associ
hospit
requir
critic
semicrit
antibiot
use
high
score
associ
inhospit
mortal
upper
lower
viral
respiratori
infect
repres
import
global
health
burden
adult
patient
due
pneumonia
children
nonetheless
role
adult
patient
less
accept
despit
progress
evid
import
outpati
clinic
set
hospit
immunosuppress
patient
unrecogn
role
chang
recent
avail
molecular
diagnost
test
enhanc
knowledg
viral
agent
work
report
season
clinic
featur
outcom
adult
patient
hospit
year
sever
respiratori
acut
infect
secondari
human
rhinoviru
infect
gener
hospit
hospit
militar
santiago
one
six
activ
surveil
center
acut
sever
respiratori
infect
requir
admiss
system
launch
juli
pan
american
health
organ
paho
chilean
ministri
health
influenza
pandem
recogn
new
respiratori
viral
threat
attend
activ
retir
militari
personnel
rel
averag
age
admit
patient
year
prospect
descript
studi
includ
adult
patient
year
admit
due
sever
acut
respiratori
infect
sari
associ
confirm
human
rhinoviru
detect
obtain
respiratori
sampl
year
see
sari
defin
presenc
fever
respiratori
symptom
associ
either
tachypnea
min
low
digit
puls
oxymetri
room
air
patient
fulfil
criteria
report
onlin
central
surveil
system
nasopharyng
swab
sampl
assess
local
level
presenc
influenza
ab
respiratori
syncyti
viru
parainfluenza
adenoviru
human
metapneumoviru
indirect
immunofluoresc
use
commerci
reagent
influenza
b
posit
sampl
well
neg
sampl
refer
refer
laboratori
instituto
de
salud
isp
analys
use
molecular
techniqu
influenza
viru
test
sub
type
molecular
kit
noninfluenza
respiratori
virus
use
kit
provid
cdc
latter
allow
detect
pcr
adenoviru
respiratori
syncyti
viru
human
metapneumoviru
parainfluenza
well
rhinoviru
hrv
includ
initi
immunofluoresc
panel
nucleic
acid
extract
use
autom
easi
mag
system
biomerieux
amplif
perform
use
ag
path
id
kit
ambion
real
time
thermo
cycler
appli
biosystem
result
posit
hrv
detect
avail
hospit
case
analyz
accord
demograph
inform
season
comorbid
clinic
present
includ
chest
xray
pafio
outcom
moment
discharg
topic
collect
prospect
demograph
comorbid
vaccin
histori
tobacco
smoke
place
hospit
retrospect
clinic
present
symptom
laboratori
data
manag
sever
score
outcom
respiratori
failur
defin
pafio
grade
result
shown
descript
manner
factor
associ
mortal
identifi
calcul
odd
ratio
respect
confid
interv
two
sever
score
cappiro
calcul
compar
predict
inhospit
mortal
thirtytwo
confirm
patient
singl
sever
episod
hrv
infect
admit
case
present
season
pattern
along
year
detect
continu
month
march
octob
summer
spring
southern
hemispher
fig
adult
patient
admit
sari
year
confirm
viral
etiolog
hrv
rank
second
influenza
infect
versu
influenza
mean
age
elev
year
older
year
tabl
two
patient
live
longterm
care
facil
near
bedridden
patient
two
comorbid
mainli
chronic
pulmonari
condit
heart
diseas
diabet
mellitu
neurolog
diseas
cancer
morbid
obes
kidney
diseas
common
case
associ
chronic
liver
diseas
one
patient
immunosuppress
previou
tobacco
smoke
affect
near
third
popul
current
smoke
still
admit
two
patient
almost
onethird
patient
chronic
lung
diseas
domiciliari
oxygen
user
tabl
patient
admit
diagnosi
communityacquir
pneumonia
follow
chronic
obstruct
pulmonari
diseas
copd
exacerb
condit
tabl
symptom
descend
order
frequenc
cough
sputum
fever
nearli
half
case
confusiondisorient
tabl
latter
manifest
strongli
associ
previou
neurolog
diseas
seven
patient
neurolog
condit
present
disorient
confus
compar
two
without
comorbid
ci
p
classic
upper
respiratori
symptom
headach
rhinorrhea
odynophagia
less
frequent
patient
present
diarrhea
two
develop
nausea
abdomin
pain
bronchial
obstruct
sign
common
find
associ
chronic
symptom
evolv
one
day
admiss
averag
five
mean
three
day
present
symptom
less
seven
day
hospit
nearli
twothird
patient
hospit
first
consult
tabl
physic
laboratori
find
shown
tabl
part
sever
respiratori
infect
definit
use
work
patient
present
tachypnea
low
satur
respiratori
failur
pafio
pafio
half
fever
leukocytosi
neutrophilia
elev
erythrocyt
sediment
rate
plasmat
ldh
bun
remark
hyponatremia
anecdot
tabl
interest
lymphopenia
creactiv
protein
crp
mgl
frequent
find
viral
agent
detect
patient
rtpcr
blood
cultur
taken
nine
patient
without
demonstr
pathogen
microorgan
two
case
present
urinari
pneumococc
antigen
detect
one
hypotens
score
interstiti
n
consolid
n
mix
n
pattern
observ
chest
xray
onethird
normal
imag
n
pleural
effus
also
record
n
ten
patient
transfer
intermedi
care
unit
n
coronari
unit
n
tabl
six
patient
requir
noninvas
mechan
support
addit
one
patient
evolv
acut
lung
edema
secondari
heart
failur
antibiot
oseltamivir
use
frequent
tabl
four
patient
die
inhospit
mortal
mean
length
stay
lo
day
rang
remain
hospit
week
tabl
score
point
present
popul
n
valu
consid
cutoff
ambulatori
manag
whole
group
factor
associ
mortal
curb
score
ci
p
bilater
fisher
test
signific
among
patient
pneumonia
area
curv
auc
obtain
receiv
oper
curv
roc
predict
inhospit
mortal
score
ci
fig
ci
subgroup
pneumonia
valu
significantli
differ
fig
use
cutoff
score
point
predict
mortal
sensit
specif
cutoff
score
subgroup
pneumonia
possibl
determin
due
small
number
patient
deceas
condit
n
auc
cappiro
score
demonstr
futil
predict
mortal
fig
deceas
patient
associ
pneumococc
infect
two
pneumonia
chest
xray
hrv
progress
recogn
one
lead
caus
acut
respiratori
infect
among
adult
patient
ambulatori
inpati
set
frequenc
may
surpass
viral
agent
caus
respiratori
infect
admiss
hrv
infect
associ
asthmat
crisi
chronic
medic
condit
malign
immunosuppress
occur
influenza
season
beyond
timefram
addit
hrv
associ
outbreak
increas
casefat
ratio
spectrum
clinic
ill
adult
includ
asthma
exacerb
chronic
pulmonari
obstruct
heart
failur
pneumonia
detail
descript
adult
patient
affect
hrv
scarc
expans
molecular
techniqu
recent
besid
casemix
etiolog
bia
toward
sever
ill
patient
work
aim
character
season
clinic
featur
adult
patient
admit
hrv
infect
one
year
activ
surveil
sever
find
case
seri
deserv
comment
first
hrv
infect
prolong
season
encompass
three
quarter
year
repres
nearli
quarter
adult
hospit
sari
known
viral
caus
underscor
medic
pathogen
relev
influenza
remain
import
prospect
studi
describ
previous
author
shown
hrv
infect
prolong
season
among
viral
caus
pneumonia
adult
surpass
influenza
adenoviru
coronaviru
respiratori
syncyti
viru
parainfluenza
second
indic
other
hrvassoci
hospit
affect
elderli
frail
patient
chronic
comorbid
past
current
histori
smoke
third
admiss
relev
prolong
requir
intermedi
intens
care
resourc
nearli
case
case
fatal
rate
profil
describ
literatur
underscor
relev
viral
agent
way
comparison
mortal
season
pandem
influenza
similar
proport
hrv
infect
patient
requir
hospit
depend
popul
studi
intens
search
addit
hrv
frequent
encount
symptomat
adult
patient
control
demonstr
pathogen
relev
fact
indic
hrv
infect
longer
consid
minor
nuisanc
diagnost
search
justifi
fourth
clinic
manifest
variabl
modul
underli
condit
cardiac
neurolog
pulmonari
diseas
tobacco
smoke
case
present
communityacquir
pneumonia
decompens
chronic
condit
fever
univers
present
low
grade
upper
respiratori
ill
hallmark
fifth
best
knowledg
mortal
risk
factor
describ
hrv
infect
adult
although
high
sever
score
link
pneumococc
coinfect
higher
mortal
regist
curb
line
origin
report
score
system
provid
evid
suitabl
approach
hrv
infect
even
patient
pneumonia
fact
auc
roc
analysi
whole
group
pneumonia
subgroup
reveal
differ
suggest
distinct
patient
without
respiratori
infiltr
perhap
necessari
patient
affect
hrv
infect
side
despit
sever
admiss
nearli
patient
low
score
specif
higher
score
low
predict
mortal
indic
limit
util
surrog
marker
risk
cappiro
score
demonstr
useless
cutoff
calcul
attempt
limit
observ
recogn
patient
need
admiss
probabl
relat
infrequ
presenc
hypotens
viral
respiratori
ill
fact
low
digit
puls
oxymetri
consid
risk
evalu
sens
current
criteria
adopt
chilean
ministri
health
togeth
pan
american
health
organ
appear
better
adapt
recogn
sever
ill
patient
affect
respiratori
viral
diseas
hrv
infect
appear
associ
wide
spectrum
diseas
abl
rapidli
decompens
vulner
patient
reflect
rel
short
symptomat
period
admiss
high
rate
hospit
first
medic
visit
probabl
distinct
clinic
differ
viral
bacteri
pneumonia
adult
lobar
condens
leukocytosi
hyponatremia
frequent
describ
patient
bacteri
diseas
overlap
common
accord
report
patient
character
minor
chang
paramet
low
frequenc
consolid
hand
neutrophilia
lymphopenia
elev
creactiv
protein
mgl
frequent
find
work
neutrophilia
commonli
found
adult
patient
hospit
differ
agent
viral
pneumonia
less
frequent
influenza
case
lymphopenia
describ
patient
pandem
influenza
sar
metapneumoviru
infect
crp
increas
fraction
patient
admit
influenza
unfortun
result
viral
diagnos
avail
time
studi
could
use
deescal
antibiot
therapi
suspend
antivir
influenza
therapi
know
specif
viral
etiolog
one
hand
associ
reduct
antibiot
consumpt
patient
respiratori
viral
ill
hand
presenc
abnorm
lung
find
prompt
antibiot
continu
despit
recogn
viral
infect
moreov
probabl
viralbacteri
coinfect
anoth
modul
factor
influenc
antibiot
therapeut
decis
bacterialvir
coinfect
rate
variabl
among
patient
respiratori
infect
rang
full
array
rapid
diagnost
techniqu
etiolog
agent
avail
would
difficult
curtail
deescal
antibiot
consumpt
imper
effort
medic
educ
necessari
viral
diagnosi
even
normal
chest
xray
consid
clinician
suffici
stop
antibiot
emerg
antibiot
resist
clostridium
difficil
verg
diagnost
shortcom
work
limit
requir
comment
hrv
detect
week
infect
amplifi
respiratori
sampl
gener
suboptim
specif
howev
univers
limit
present
across
studi
invalid
scientif
evid
show
similar
result
differ
scenario
addit
systemat
search
respiratori
bacteri
pathogen
carri
studi
make
possibl
part
result
explain
coinfect
case
least
two
patient
believ
factor
rather
secondari
patient
neg
blood
cultur
report
frequenc
viralbacteri
coinfect
high
literatur
hand
viralvir
coinfect
could
demonstr
patient
make
find
unbias
contribut
viral
respiratori
agent
frequenc
viralvir
coinfect
appear
low
adult
respiratori
infect
final
result
work
deriv
stringent
criteria
sever
necessarili
repres
case
mild
diseas
work
provid
evid
hrv
import
respiratori
pathogen
among
patient
admit
sari
due
rel
high
frequenc
also
hrv
infect
abl
tumbl
vulner
adult
patient
associ
wide
spectrum
ill
use
intermedi
critic
care
resourc
sometim
associ
prolong
hospit
death
addit
absenc
time
diagnosi
hrv
viral
respiratori
pathogen
contribut
inappropri
antibiot
use
